China Opens Door For Foreigners Post-Pandemic, But Only If They Get Chinese Vaccine

China Coronavirus Covid-19

China has made this rule at a time when it is trying to promote its medicines around the world. At present, China has vaccinated 65 million of its citizens.

China, which prohibited the entry of foreigners in the Coronavirus period, has now started allowing entry of foreigners in the country. However, the country has decided to give visas only to those who have received the Corona vaccine jab made in China. The Chinese Embassy in New Delhi gave this information on Tuesday. In such a situation, it will not be easy for Indians to go to the Chinese province since the country has not approved the Corona vaccine made in China. Apart from this, there is no direct air service between India and China at present.

The statement issued by the Chinese embassy said that this was done for the convenience of people visiting the country. The Chinese Embassy said that the government has taken this decision for the convenience of people who want to go to study, business and to visit relatives. However, the Chinese embassy has not made it clear to whom the decision will apply. Explain that a large number of Indian students live in China. Around 22,000 students study in the country, who are currently in India because it has not yet given them entry into their country.

Also Read: Govt Also Builds Roads, Do Only Govt Vehicle Run On It? Railway Minister Piyush Goyal Asks

India has not yet given approval to the Chinese vaccine. At present, India has rolled out two vaccine candidates: Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.

China has made this rule at a time when it is trying to promote its medicines around the world. At present, the Chinese Govt has vaccinated 65 million of its citizens. Apart from this, it is also providing his vaccine to many other countries. However, due to the lack of transparency in clinical trial data and other reasons, many countries have not approved the Chinese vaccine. However, in Africa and Latin American countries, it has been successful in selling its vaccine.


Next Story
Share it
Top
To Top